Experience

IBt - Instituto de Biotecnología UNAM

• • Jan 2017 - Present

• • Jun 2014 - Dec 2017

  I worked coordinating projects of industries for the production of potential biotechnological medicines. I participated generating a quality management system of the Laboratorio Nacional para la producción y Análisis de Moléculas y Medicamentos Biotecnológicos (LAMMB), which is a third-party laboratory authorized by COFEPRIS that provides characterization services for proteins and biotechnological medicines. I lead the quality assurance area to ensure the quality of the results, as well as participated in audits of pharmaceutical companies. Show less



Instituto Nacional de Salud Pública

• Higher Education
• 200 - 300 Employee

• • Apr 2013 - Apr 2014

  Investigating the interaction of transcription factors with specific DNA sequences. I worked with laboratory techniques of molecular biology such as EMSAs, molecular cloning, cell culture, electrophoresis for DNA and proteins. I worked in lab organization such as doing inventories.

• • Sep 2010 - Mar 2013

  Effect of HPV E6 and E7 silencing mediated by siRNAs in an HPV16+ tumor model



UAEM

• Netherlands
• Hospitals and Health Care
• 1 - 100 Employee

• Bachelor in Pharmacy

  • Feb 2008 - Feb 2010

  I worked on the characterization of cell death of the human embryonic kidney cell line (HEK293). Growth kinetics of adherent cultures were performed and cell death was characterized in response to different stimuli such as starvation and infection with adenovirus 5 wild-type. The techniques used to characterize cell death were: epifluorescence microscopy and flow cytometry. I worked on the characterization of cell death of the human embryonic kidney cell line (HEK293). Growth kinetics of adherent cultures were performed and cell death was characterized in response to different stimuli such as starvation and infection with adenovirus 5 wild-type. The techniques used to characterize cell death were: epifluorescence microscopy and flow cytometry.